307 related articles for article (PubMed ID: 28407787)
1. Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B.
Zheng NQ; Zheng ZH; Xu HX; Huang MX; Peng XM
Virol J; 2017 Apr; 14(1):77. PubMed ID: 28407787
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus enhances cisplatin-induced hepatotoxicity via a mechanism involving suppression of glucose-regulated protein of 78 Kda.
Zhang X; Zhang R; Yang H; Xiang Q; Jiang Q; He Q; Zhang T; Chen C; Zhu H; Wang Q; Ning Q; Li Y; Lei P; Shen G
Chem Biol Interact; 2016 Jul; 254():45-53. PubMed ID: 27234046
[TBL] [Abstract][Full Text] [Related]
3. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus.
Ma Y; Yu J; Chan HL; Chen YC; Wang H; Chen Y; Chan CY; Go MY; Tsai SN; Ngai SM; To KF; Tong JH; He QY; Sung JJ; Kung HF; Cheng CH; He ML
Mol Cell Proteomics; 2009 Nov; 8(11):2582-94. PubMed ID: 19671925
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.
Pang YJ; Tan XJ; Li DM; Zheng ZH; Lei RX; Peng XM
Liver Int; 2013 Sep; 33(8):1230-8. PubMed ID: 23617302
[TBL] [Abstract][Full Text] [Related]
5. Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.
Yang HY; Zheng NQ; Li DM; Gu L; Peng XM
Virol J; 2014 Sep; 11():165. PubMed ID: 25224377
[TBL] [Abstract][Full Text] [Related]
6. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
7. Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
J Viral Hepat; 2009 May; 16(5):367-75. PubMed ID: 19228285
[TBL] [Abstract][Full Text] [Related]
8. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues.
Qiu D; Chen J; Liu J; Luo Z; Jiang W; Huang J; Qiu Z; Yue W; Wu L
Exp Biol Med (Maywood); 2017 May; 242(9):939-944. PubMed ID: 28440732
[TBL] [Abstract][Full Text] [Related]
9. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
J Virol; 2020 May; 94(11):. PubMed ID: 32188736
[TBL] [Abstract][Full Text] [Related]
10. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.
She S; Yang M; Hu H; Hu P; Yang Y; Ren H
Cell Physiol Biochem; 2018; 45(2):744-760. PubMed ID: 29414802
[TBL] [Abstract][Full Text] [Related]
11. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes.
Wu JF; Hsu HY; Ni YH; Chen HL; Wu TC; Chang MH
Am J Pathol; 2012 Jul; 181(1):19-25. PubMed ID: 22634051
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
[TBL] [Abstract][Full Text] [Related]
13. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
[TBL] [Abstract][Full Text] [Related]
14. Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis.
Zheng J; Jiang S; Lu F
Jpn J Infect Dis; 2016 Jul; 69(4):306-13. PubMed ID: 26567840
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatitis B viral replication and proteomic analysis of HepG2.2.15 cell line after knockdown of HBx.
Xie HY; Cheng J; Xing CY; Wang JJ; Su R; Wei XY; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):295-302. PubMed ID: 21669574
[TBL] [Abstract][Full Text] [Related]
16. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis.
Zhang Y; Li Y; Ma Y; Liu S; She Y; Zhao P; Jing M; Han T; Yan C; Wu Z; Gao J; Ye L
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G565-73. PubMed ID: 21719740
[TBL] [Abstract][Full Text] [Related]
19. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
20. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
